Suprabasin as a novel tumor endothelial cell marker

被引:37
作者
Alam, Mohammad T. [1 ,2 ]
Nagao-Kitamoto, Hiroko [1 ]
Ohga, Noritaka [1 ]
Akiyama, Kosuke [1 ]
Maishi, Nako [1 ]
Kawamoto, Taisuke [1 ]
Shinohara, Nobuo [3 ]
Taketomi, Akinobu [4 ]
Shindoh, Masanobu [2 ]
Hida, Yasuhiro [5 ]
Hida, Kyoko [1 ]
机构
[1] Hokkaido Univ, Inst Med Genet, Frontier Res Unit, Sapporo, Hokkaido 0600815, Japan
[2] Hokkaido Univ, Grad Sch Dent Med, Dept Oral Pathol & Biol, Sapporo, Hokkaido 0600815, Japan
[3] Hokkaido Univ, Grad Sch Med, Dept Renal & Genitourinary Surg, Sapporo, Hokkaido 0600815, Japan
[4] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol Surg 1, Sapporo, Hokkaido 0600815, Japan
[5] Hokkaido Univ, Grad Sch Med, Dept Cardiovasc & Thorac Surg, Sapporo, Hokkaido 0600815, Japan
关键词
Angiogenesis; suprabasin; suprabasin signaling; tumor endothelial cell marker; tumor endothelial cells; PROMOTES ANGIOGENESIS; CANCER; VEGF; ABNORMALITIES; METASTASIS; DISCOVERY; CARCINOMA; RECEPTOR;
D O I
10.1111/cas.12549
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Recent studies have reported that stromal cells contribute to tumor progression. We previously demonstrated that tumor endothelial cells (TEC) characteristics were different from those of normal endothelial cells (NEC). Furthermore, we performed gene profile analysis in TEC and NEC, revealing that suprabasin (SBSN) was upregulated in TEC compared with NEC. However, its role in TEC is still unknown. Here we showed that SBSN expression was higher in isolated human and mouse TEC than in NEC. SBSN knockdown inhibited the migration and tube formation ability of TEC. We also showed that the AKT pathway was a downstream factor of SBSN. These findings suggest that SBSN is involved in the angiogenic potential of TEC and may be a novel TEC marker.
引用
收藏
页码:1533 / 1540
页数:8
相关论文
共 31 条
[1]   Cytogenetic Abnormalities of Tumor-Associated Endothelial Cells in Human Malignant Tumors [J].
Akino, Tomoshige ;
Hida, Kyoko ;
Hida, Yasuhiro ;
Tsuchiya, Kunihiko ;
Freedman, Deborah ;
Muraki, Chikara ;
Ohga, Noritaka ;
Matsuda, Kouhei ;
Akiyama, Kousuke ;
Harabayashi, Toru ;
Shinohara, Nobuo ;
Nonomura, Katsuya ;
Klagsbrun, Michael ;
Shindoh, Masanobu .
AMERICAN JOURNAL OF PATHOLOGY, 2009, 175 (06) :2657-2667
[2]   The F-prostaglandin receptor is a novel marker for tumor endothelial cells in renal cell carcinoma [J].
Akiyama, Kosuke ;
Ohga, Noritaka ;
Maishi, Nako ;
Hida, Yasuhiro ;
Kitayama, Kazuko ;
Kawamoto, Taisuke ;
Osawa, Takahiro ;
Suzuki, Yuko ;
Shinohara, Nobuo ;
Nonomura, Katsuya ;
Shindoh, Masanobu ;
Hida, Kyoko .
PATHOLOGY INTERNATIONAL, 2013, 63 (01) :37-44
[3]   Tumor Endothelial Cells Acquire Drug Resistance by MDR1 Up-Regulation via VEGF Signaling in Tumor Microenvironment [J].
Akiyama, Kosuke ;
Ohga, Noritaka ;
Hida, Yasuhiro ;
Kawamoto, Taisuke ;
Sadamoto, Yoshihiro ;
Ishikawa, Shuhei ;
Maishi, Nako ;
Akino, Tomoshige ;
Kondoh, Miyako ;
Matsuda, Aya ;
Inoue, Nobuo ;
Shindoh, Masanobu ;
Hide, Kyoko .
AMERICAN JOURNAL OF PATHOLOGY, 2012, 180 (03) :1283-1293
[4]   Altered angiogenesis and survival in human tumor-derived endothelial cells [J].
Bussolati, B ;
Deambrosis, I ;
Russo, S ;
Deregibus, MC ;
Camussi, G .
FASEB JOURNAL, 2003, 17 (06) :1159-+
[5]   Role of angiogenesis in tumor growth and metastasis [J].
Folkman, J .
SEMINARS IN ONCOLOGY, 2002, 29 (06) :15-18
[6]   Opinion - Angiogenesis: an organizing principle for drug discovery? [J].
Folkman, Judah .
NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (04) :273-286
[7]   Secretome Signature of Invasive Glioblastoma Multiforme [J].
Formolo, Catherine A. ;
Williams, Russell ;
Gordish-Dressman, Heather ;
MacDonald, Tobey J. ;
Lee, Norman H. ;
Hathout, Yetrib .
JOURNAL OF PROTEOME RESEARCH, 2011, 10 (07) :3149-3159
[8]   Integrative Discovery of Epigenetically Derepressed Cancer Testis Antigens in NSCLC [J].
Glazer, Chad A. ;
Smith, Ian M. ;
Ochs, Michael F. ;
Begum, Shahnaz ;
Westra, William ;
Chang, Steven S. ;
Sun, Wenyue ;
Bhan, Sheetal ;
Khan, Zubair ;
Ahrendt, Steven ;
Califano, Joseph A. .
PLOS ONE, 2009, 4 (12)
[9]   Tumor-associated endothelial cells with cytogenetic abnormalities [J].
Hida, K ;
Hida, Y ;
Amin, DN ;
Flint, AF ;
Panigrahy, D ;
Morton, CC ;
Klagsbrun, M .
CANCER RESEARCH, 2004, 64 (22) :8249-8255
[10]   An overview of small-molecule inhibitors of VEGFR signaling [J].
Ivy, S. Percy ;
Wick, Jeannette Y. ;
Kaufman, Bennett M. .
NATURE REVIEWS CLINICAL ONCOLOGY, 2009, 6 (10) :569-579